These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2120806)

  • 21. Differential maturation of avidity of IgG antibodies to gp41, p24 and p17 following infection with HIV-1.
    Thomas HI; Wilson S; O'Toole CM; Lister CM; Saeed AM; Watkins RP; Morgan-Capner P
    Clin Exp Immunol; 1996 Feb; 103(2):185-91. PubMed ID: 8565298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. False-positive human immunodeficiency virus type 1 western blot tests in noninfected blood donors.
    Sayre KR; Dodd RY; Tegtmeier G; Layug L; Alexander SS; Busch MP
    Transfusion; 1996 Jan; 36(1):45-52. PubMed ID: 8607152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins.
    Lottersberger J; Salvetti JL; Beltramini LM; Tonarelli G
    Rev Argent Microbiol; 2004; 36(4):151-7. PubMed ID: 15786866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 7-year analysis of anti-Gag (p17 and p24) antibodies in HIV-1-seropositive patients with haemophilia: immunoglobulin G titre and avidity are early predictors of clinical course.
    Chargelegue D; Colvin BT; O'Toole CM
    AIDS; 1993 Nov; 7 Suppl 2():S87-90. PubMed ID: 7909231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resolution of infection status of human immunodeficiency virus (HIV)-seroindeterminate donors and high-risk seronegative individuals with polymerase chain reaction and virus culture: absence of persistent silent HIV type 1 infection in a high-prevalence area.
    Eble BE; Busch MP; Khayam-Bashi H; Nason MA; Samson S; Vyas GN
    Transfusion; 1992; 32(6):503-8. PubMed ID: 1502702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening potential corneal donors for HIV-1 by polymerase chain reaction and a colorimetric microwell hybridization assay.
    Essary LR; Kinard SJ; Butcher A; Wang H; Laycock KA; Donegan E; McCreedy B; Connell S; Batchelor J; Harris J; Spadoro J; Pepose JS
    Am J Ophthalmol; 1996 Oct; 122(4):526-34. PubMed ID: 8862050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decline in CTL and antibody responses to HIV-1 p17 and p24 antigens in HIV-1-infected hemophiliacs irrespective of disease progression. A 5-year follow-up study.
    O'Toole CM; Lowdell MW; Chargelegue D; Colvin BT
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1361-8. PubMed ID: 1281655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shortening of the window period in diagnosis of HIV-1 infection by simultaneous detection of p24 antigen and antibody IgG to p17 and reverse transcriptase in serum with ultrasensitive enzyme immunoassay.
    Hashida S; Hashinaka K; Nishikata I; Oka S; Shimada K; Saito A; Takamizawa A; Shinagawa H; Ishikawa E
    J Virol Methods; 1996 Oct; 62(1):43-53. PubMed ID: 8910647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV reverse transcriptase inhibiting antibodies detected by a new technique: relation to p24 and gp41 antibodies, HIV antigenemia and clinical variables.
    Neumüller M; Karlsson A; Lennerstrand J; Källander CF; Holmberg V; Långström-Persson U; Thorstensson R; Sandström E; Gronowitz JS
    J Med Virol; 1991 May; 34(1):55-63. PubMed ID: 1715898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance characteristics of a novel immunoassay based on hybrid Ty virus-like particles (Ty-VLPs): rapid differentiation between HIV-1 and HIV-2 infection.
    Gilmour JE; Read SJ; Eglin R; Ryan C; Burns NR; Graff N; Stenner N; Kingsman SM; Kingsman AJ; Adams SE
    AIDS; 1990 Oct; 4(10):967-73. PubMed ID: 2124493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetics of p24 antigenemia, IgM, IgG antibodies to p24 and p41 and Ig virus isolation in rabbits experimentally infected with HIV-1.
    Filice G; Cereda PM; Orsolini P; Soldini L; Romero E; Rondanelli EG
    Microbiologica; 1990 Jul; 13(3):215-24. PubMed ID: 2125683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of regions of HIV-1 p24 reactive with sera which give "indeterminate" results in electrophoretic immunoblots with the help of long synthetic peptides.
    Blomberg J; Vincic E; Jönsson C; Medstrand P; Pipkorn R
    AIDS Res Hum Retroviruses; 1990 Dec; 6(12):1363-72. PubMed ID: 2127683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New sensitive and specific assay for human immunodeficiency virus antibodies using labeled recombinant fusion protein and time-resolved fluoroimmunoassay.
    Siitari H; Turunen P; Schrimsher J; Nunn M
    J Clin Microbiol; 1990 Sep; 28(9):2022-9. PubMed ID: 2121790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Yeast-expressed p55 precursor core protein of human immunodeficiency virus type 1 does not elicit protective immunity in chimpanzees.
    Emini EA; Schleif WA; Quintero JC; Conard PG; Eichberg JW; Vlasuk GP; Lehman ED; Polokoff MA; Schaeffer TF; Schultz LD
    AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1247-50. PubMed ID: 2127681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The polymerase chain reaction in the diagnosis of vertically transmitted HIV infection.
    Williams P; Simmonds P; Yap PL; Balfe P; Bishop J; Brettle R; Hague R; Hargreaves D; Inglis J; Brown AL
    AIDS; 1990 May; 4(5):393-8. PubMed ID: 2115340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PCR analysis of HIV-seronegative, heterosexual partners of HIV-infected individuals.
    Palumbo P; Skurnick J; Lewis D; Eisenberg M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(4):436-40. PubMed ID: 7583439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV P24 antigen among HIV antibody seronegative blood donors in Osogbo Osun State, South Western Nigeria.
    Olowe OA; Mabayoje VO; Akanbi O; Adefioye OJ; Olowe RA; Fadeni EK; Oluremi AS; Opaleye OO
    Pathog Glob Health; 2016; 110(4-5):205-8. PubMed ID: 27386900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epitope location of 13 anti-gag HIV-1 monoclonal antibodies using oligopeptides and their cross reactivity with HIV-2.
    Ferns RB; Partridge JC; Spence RP; Hunt N; Tedder RS
    AIDS; 1989 Dec; 3(12):829-34. PubMed ID: 2483619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistent lack of detectable HIV-1 antibody in a person with HIV infection--Utah, 1995.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Mar; 45(9):181-5. PubMed ID: 8604214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequent detection of HIV-1-specific mRNAs in infected individuals suggests ongoing active viral expression in all stages of disease.
    Schnittman SM; Greenhouse JJ; Lane HC; Pierce PF; Fauci AS
    AIDS Res Hum Retroviruses; 1991 Apr; 7(4):361-7. PubMed ID: 1676896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.